336 related articles for article (PubMed ID: 8817406)
1. Effects of moderate salt restriction alone and in combination with cilazapril on office and ambulatory blood pressure.
Uusitupa M; Korhonen M; Litmanen H; Niskanen L; Väisänen S; Rauramaa R
J Hum Hypertens; 1996 May; 10(5):319-26. PubMed ID: 8817406
[TBL] [Abstract][Full Text] [Related]
2. Antihypertensive efficacy of cilazapril 2.5 and 5.0 mg once-daily versus placebo on office blood pressure and 24-hour blood pressure profile.
Prager G; Klein P; Schmitt M; Prager R
J Cardiovasc Pharmacol; 1994; 24 Suppl 3():S93-9. PubMed ID: 7700076
[TBL] [Abstract][Full Text] [Related]
3. Albuminuria in diabetes mellitus: relation to ambulatory versus office blood pressure and effects of cilazapril.
Waeber B; Weidmann P; Wohler D; Le Bloch Y
Am J Hypertens; 1996 Dec; 9(12 Pt 1):1220-7. PubMed ID: 8972894
[TBL] [Abstract][Full Text] [Related]
4. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
[TBL] [Abstract][Full Text] [Related]
5. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].
Qiu YG; Yao XY; Tao QM; Zheng P; Chen JZ; Zhu JH; Zhang FR; Zheng LR; Zhao LL
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399
[TBL] [Abstract][Full Text] [Related]
6. Hemodynamic and 24-h blood pressure profile of amlodipine monotherapy.
Ibrahim MM; el-Boghdadly B; Zaghloul SS
J Hum Hypertens; 1996 Jul; 10(7):489-94. PubMed ID: 8880565
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and tolerability of 5 mg of cilazapril plus 12.5 mg of hydrochlorothiazide in mild-to-moderate hypertension: results of 24-hour ambulatory blood pressure monitoring.
Martina B; Weinbacher M; Gasser P; Rhyner K; Köhler M; Wohler D; LeBloch Y; Bart T
J Cardiovasc Pharmacol; 1994; 24 Suppl 3():S89-92. PubMed ID: 7700075
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of low felodipine dose monotherapy in mild-to-moderate hypertension: a comparison between office and ambulatory blood pressure monitoring.
Podjarny E; Korzets Z; Bernheim J
J Hum Hypertens; 1996 Sep; 10 Suppl 3():S153-6. PubMed ID: 8872849
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of the effects of the angiotensin converting enzyme inhibitor cilazapril on diurnal blood pressure.
Nakanishi T; Takahashi H; Nishimura M; Yoshimura M
Clin Ther; 1993; 15(2):294-303. PubMed ID: 8519038
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the antihypertensive effects of the fixed dose combination enalapril 10 mg/nitrendipine 20 mg vs losartan 50 mg/hydrochlorothiazide 12.5 mg, assessed by 24-h ambulatory blood pressure monitoring, in essential hypertensive patients.
de la Sierra A; Gil-Extremera B; Calvo C; Campo C; García-Puig J; Márquez E; Oliván J; Roca Cusachs A; Sanz de Castro S; Pontes C; Delgadillo J
J Hum Hypertens; 2004 Mar; 18(3):215-22. PubMed ID: 14973517
[TBL] [Abstract][Full Text] [Related]
11. Moderate salt restriction effectively lowers blood pressure and degree of salt sensitivity is related to baseline concentration of renin and N-terminal atrial natriuretic peptide in plasma.
Melander O; von Wowern F; Frandsen E; Burri P; Willsteen G; Aurell M; Hulthén UL
J Hypertens; 2007 Mar; 25(3):619-27. PubMed ID: 17278979
[TBL] [Abstract][Full Text] [Related]
12. Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: the REASON study.
Mallion JM; Chamontin B; Asmar R; De Leeuw PW; O'Brien E; Duprez D; O'Rourke MF; Rahn KH; Romero R; Battegay E; Hitzenberger G; Safar ME;
Am J Hypertens; 2004 Mar; 17(3):245-51. PubMed ID: 15001199
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of decreased albuminuria caused by angiotensin converting enzyme inhibitor in early diabetic nephropathy.
Imanishi M; Yoshioka K; Okumura M; Konishi Y; Tanaka S; Fujii S; Kimura G
Kidney Int Suppl; 1997 Dec; 63():S198-200. PubMed ID: 9407458
[TBL] [Abstract][Full Text] [Related]
14. Rosiglitazone reduces office and diastolic ambulatory blood pressure following 1-year treatment in non-diabetic subjects with insulin resistance.
Nilsson PM; Hedblad B; Donaldson J; Berglund G
Blood Press; 2007; 16(2):95-100. PubMed ID: 17612907
[TBL] [Abstract][Full Text] [Related]
15. Changing the timing of antihypertensive therapy to reduce nocturnal blood pressure in CKD: an 8-week uncontrolled trial.
Minutolo R; Gabbai FB; Borrelli S; Scigliano R; Trucillo P; Baldanza D; Laurino S; Mascia S; Conte G; De Nicola L
Am J Kidney Dis; 2007 Dec; 50(6):908-17. PubMed ID: 18037091
[TBL] [Abstract][Full Text] [Related]
16. Discrepancies between clinic and ambulatory blood pressure responses to cilazapril therapy.
Lacourcière Y; Leenen F; Rangno R; Spence JD; Lenis JH; Myers MG
Can J Cardiol; 1994; 10(6):605-10. PubMed ID: 8044721
[TBL] [Abstract][Full Text] [Related]
17. Ambulatory blood pressure characteristics in normotensive and treated hypertensive older people.
Wendelin-Saarenhovi ML; Isoaho RE; Hartiala JJ; Helenius HY; Kivelä SL; Löppönen MK; Hietanen EK
J Hum Hypertens; 2002 Mar; 16(3):177-84. PubMed ID: 11896507
[TBL] [Abstract][Full Text] [Related]
18. [Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"].
Amado P; Vasconcelos N; Santos I; Almeida L; Nazaré J; Carmona J
Rev Port Cardiol; 1999 Oct; 18(10):897-906. PubMed ID: 10590654
[TBL] [Abstract][Full Text] [Related]
19. Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high-normal blood pressure. The Trials of Hypertension Prevention, phase II. The Trials of Hypertension Prevention Collaborative Research Group.
Arch Intern Med; 1997 Mar; 157(6):657-67. PubMed ID: 9080920
[TBL] [Abstract][Full Text] [Related]
20. [Hormonal profile and participation of nitric oxide in salt-sensitive and salt-resistant essential arterial hypertension].
Gómez-Fernández P; Moreno VG; Cornejo M; Vargas JC; García-Barroso C; Velasco G; Almaraz M
Nefrologia; 2000; 20(5):415-23. PubMed ID: 11100662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
